Veronique Michaud, BPharm, PhD, is the Chief Operating Officer of the Tabula Rasa HealthCare Precision Pharmacotherapy Research & Development Institute in Lake Nona. She was previously associate professor, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida. Dr. Michaud is an adjunct professor, Faculty of Pharmacy, Université de Montréal. She directed a pharmacokinetic and bioanalytic core facility at the University of Montreal Hospital Research Center.
Dr. Michaud is recognized for her unique expertise in pharmacokinetics, drug-metabolism, drug-drug interactions, pharmacogenomics and the study of intracellular drug-metabolism. Her research investigates the contribution of CYP450 drug-metabolizing enzymes in drug disposition, with a special attention to the role of disease states (focusing on type 2 diabetes), the role of pharmacogenomics and drug-drug interactions while attempting to better understand and predict variation in drug responses. She has earned more than $22 million in research awards, published more than 58 peer-reviewed journal articles and mentored graduate students and PharmD residents.
Dr. Michaud completed fellowships at Indiana University and McGill University and earned her PhD and MSc degrees from the Université de Montréal.